One more step toward treatment of PARP inhibitor-resistant ovarian cancers
A new editorial paper titled "One more step toward treatment of PARP inhibitor-resistant ovarian cancers" has been published in Oncotarget.
Jan 10, 2024
0
2
A new editorial paper titled "One more step toward treatment of PARP inhibitor-resistant ovarian cancers" has been published in Oncotarget.
Jan 10, 2024
0
2
A national research database has revealed stark figures for cardiac arrests in England for 2022. Survival rates remain low, with around 8% patients surviving to 30 days after a cardiac arrest.
Jan 9, 2024
0
0
A new study led by Yale Cancer Center researchers at Yale School of Medicine has revealed a significant increase in patients starting immunotherapy within one month of death. Using a national clinical database, the researchers ...
Jan 4, 2024
0
12
Immune checkpoint inhibitors (ICIs) are used to treat a variety of different cancers. ICIs are antibodies that sensitize the body's own immune system to detect and destroy tumors. However, ICIs are not effective in all patients, ...
Jan 3, 2024
0
50
Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less ...
Jan 3, 2024
0
11
Because athletes young and old can suffer cardiac arrest, some states have mandated the placement of automated external defibrillators (AEDs) in gyms, stadiums and other sports venues. But a new study finds the use of AEDs ...
Jan 2, 2024
0
1
Because athletes young and old can suffer cardiac arrest, some states have mandated the placement of automated external defibrillators (AEDs) in gyms, stadiums and other sports venues. But a new study finds the use of AEDs ...
Jan 2, 2024
3
35
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia. Although potentially curable in the early stages, ...
Dec 29, 2023
0
4
For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benefit, according to a study published online ...
Dec 21, 2023
0
0
For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, ...
Dec 20, 2023
0
1